Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 55Myelodysplastic Syndromes 32Leukemia 18Leukemia, Myelomonocytic, Chronic 11Congenital Abnormalities 5Recurrence 4Neoplasms 4Melanoma 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Anemia, Refractory 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Thrombocytopenia 1Thrombocythemia, Essential 1Skin Neoplasms 1Sarcoma, Synovial 1Primary Myelofibrosis 1

Interventions

Cytarabine 23fludarabine phosphate 9Daunorubicin 9Mitoxantrone 8Busulfan 8Peripheral Blood Stem Cell Transplantation 6Methotrexate 6Idarubicin 6Gemtuzumab 6Etoposide 6Whole-Body Irradiation 5Filgrastim 5Cyclophosphamide 5Clofarabine 5tipifarnib 4alvocidib 4Vorinostat 4Tacrolimus 4Cyclosporine 4Azacitidine 4Antilymphocyte Serum 4sargramostim 3Observation 3Mycophenolic Acid 3Flow Cytometry 3Decitabine 3Cytogenetic Analysis 3Bortezomib 3fludarabine 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Leukemia, Erythroblastic, Acute × Decitabine × Clear all
NCT02085408 2024-12-13

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Eastern Cooperative Oncology Group

Phase 3 Completed
727 enrolled 13 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT01607645 2017-03-31

Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS

Fred Hutchinson Cancer Center

Phase 2 Terminated
7 enrolled 17 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02029417 2016-05-09

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 2 Terminated
2 enrolled 6 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡